BE872908A - Compositions pharmaceutiques pour le traitement de l'hypertension - Google Patents
Compositions pharmaceutiques pour le traitement de l'hypertensionInfo
- Publication number
- BE872908A BE872908A BE192434A BE192434A BE872908A BE 872908 A BE872908 A BE 872908A BE 192434 A BE192434 A BE 192434A BE 192434 A BE192434 A BE 192434A BE 872908 A BE872908 A BE 872908A
- Authority
- BE
- Belgium
- Prior art keywords
- hypertension
- treatment
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 206010020772 Hypertension Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/892,213 US4130653A (en) | 1978-03-31 | 1978-03-31 | Method of treating hypertension |
Publications (1)
Publication Number | Publication Date |
---|---|
BE872908A true BE872908A (fr) | 1979-04-17 |
Family
ID=25399562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE192434A BE872908A (fr) | 1978-03-31 | 1978-12-20 | Compositions pharmaceutiques pour le traitement de l'hypertension |
Country Status (4)
Country | Link |
---|---|
US (1) | US4130653A (fr) |
BE (1) | BE872908A (fr) |
PH (1) | PH13504A (fr) |
ZA (1) | ZA786811B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4347255A (en) * | 1980-04-17 | 1982-08-31 | Richardson-Merrell Inc. | Snake bite therapy |
US4439443A (en) * | 1981-08-07 | 1984-03-27 | Richardson-Merrell Inc. | Snake bite therapy |
US8026280B2 (en) | 2001-03-27 | 2011-09-27 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US7842727B2 (en) | 2001-03-27 | 2010-11-30 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
US6495719B2 (en) | 2001-03-27 | 2002-12-17 | Circagen Pharmaceutical | Histone deacetylase inhibitors |
WO2003099272A1 (fr) | 2002-05-22 | 2003-12-04 | Errant Gene Therapeutics, Llc | Inhibiteurs d'histone desacetylase bases sur des composes alpha-ceto-epoxydes |
JP2006508986A (ja) | 2002-11-20 | 2006-03-16 | エルラント ゲネ セラペウチクス エルエルシー | ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3452039A (en) * | 1966-05-25 | 1969-06-24 | Bristol Myers Co | Certain 5-tetrazolyl benzothiophene compounds |
US3941818A (en) * | 1973-08-20 | 1976-03-02 | Zinpro Corporation | 1:1 Zinc methionine complexes |
-
1978
- 1978-03-31 US US05/892,213 patent/US4130653A/en not_active Expired - Lifetime
- 1978-12-05 ZA ZA00786811A patent/ZA786811B/xx unknown
- 1978-12-08 PH PH21912A patent/PH13504A/en unknown
- 1978-12-20 BE BE192434A patent/BE872908A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US4130653A (en) | 1978-12-19 |
PH13504A (en) | 1980-06-03 |
ZA786811B (en) | 1979-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE851328A (fr) | Composition pour le traitement de l'hypercholesterolemie | |
BE890648A (fr) | Compositions pour le traitement de l'acne | |
BE859817A (fr) | Compositions notamment utiles pour le traitement de l'acne | |
BE854414A (fr) | Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate | |
BE865156A (fr) | Compositions pharmaceutiques pour le traitement des depressions | |
MC1525A1 (fr) | Preparation d'une composition pour le traitement de la seborrhee | |
BE872908A (fr) | Compositions pharmaceutiques pour le traitement de l'hypertension | |
BE873092A (fr) | Composition pour le traitement de l'hypertension | |
BE829859A (fr) | Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie | |
BE887639A (fr) | Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne | |
BE885291A (fr) | Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques | |
BE885290A (fr) | Compositions pharmaceutiques pour le traitement des hyperlipidemies et des hyperlipoproteinemies | |
BE858692A (fr) | Composition pour le traitement de l'acne | |
FR2340737A1 (fr) | Composition pour le traitement de l'hypercholesterolemie | |
FR2536995B1 (fr) | Composition pour le traitement de l'arthrite | |
FR2310769A1 (fr) | Medicament pour le traitement de l'alopecia seborrhoeica | |
FR2332965A1 (fr) | Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage | |
FR2526792B1 (fr) | Derives d'aletheine utiles pour le traitement des lesions hepatiques | |
BE894228A (fr) | Composition pharmaceutique pour le traitement de l'atherosclerose | |
FR2544614B1 (fr) | Nouvelle association medicamenteuse pour le traitement de l'hypertension | |
BE842389A (fr) | Composition pharmaceutique pour le traitement de l'hyperuricemie | |
FR2320738A1 (fr) | Compositions pharmaceutiques pour traiter l'hypertension | |
RO79428A2 (fr) | Composition medicamenteuse pour le traitement des dermatoses | |
RO65965A2 (fr) | Composition medicamenteuse pour le traitement d'ulcere gastroduodenel | |
FR2517203B1 (fr) | Composition pour le traitement de l'acne |